223 related articles for article (PubMed ID: 19515794)
1. A systematic evaluation of factors associated with nocturia--the population-based FINNO study.
Tikkinen KA; Auvinen A; Johnson TM; Weiss JP; Keränen T; Tiitinen A; Polo O; Partinen M; Tammela TL
Am J Epidemiol; 2009 Aug; 170(3):361-8. PubMed ID: 19515794
[TBL] [Abstract][Full Text] [Related]
2. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
[TBL] [Abstract][Full Text] [Related]
3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
4. Nocturia and obesity: a population-based study in Finland.
Tikkinen KA; Auvinen A; Huhtala H; Tammela TL
Am J Epidemiol; 2006 Jun; 163(11):1003-11. PubMed ID: 16597705
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.
Chow PM; Liu SP; Chuang YC; Lee KS; Yoo TK; Liao L; Wang JY; Liu M; Sumarsono B; Jong JJ
World J Urol; 2018 Nov; 36(11):1853-1862. PubMed ID: 29796775
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland.
Tikkinen KA; Auvinen A; Tiitinen A; Valpas A; Johnson TM; Tammela TL
Am J Obstet Gynecol; 2008 Aug; 199(2):153.e1-12. PubMed ID: 18486094
[TBL] [Abstract][Full Text] [Related]
7. Smoking and bladder symptoms in women.
Tähtinen RM; Auvinen A; Cartwright R; Johnson TM; Tammela TLJ; Tikkinen KAO
Obstet Gynecol; 2011 Sep; 118(3):643-648. PubMed ID: 21860295
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of nocturia (two or more voids per night) in Chinese people older than 40 years.
Wen L; Wen YB; Wang ZM; Wen JG; Li ZZ; Shang XP; Liu ZS; Jia LH; Qin GJ; Heesakkers J; Corcos J; Djurhuus JC
Neurourol Urodyn; 2015 Aug; 34(6):566-70. PubMed ID: 24788681
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal Polyuria and Hypertension in Patients with Lifestyle Related Diseases and Overactive Bladder.
Yokoyama O; Nishizawa O; Homma Y; Takeda M; Gotoh M; Kakizaki H; Akino H; Hayashi K; Yonemoto K;
J Urol; 2017 Feb; 197(2):423-431. PubMed ID: 27565397
[TBL] [Abstract][Full Text] [Related]
10. Burden of benign prostatic hyperplasia among men in Japan: Patient-reported outcomes among those diagnosed and experiencing symptoms.
Yoshida M; Flores NM; Vietri J; Lee M; Murakami M
Int J Urol; 2015 Oct; 22(10):949-55. PubMed ID: 26138017
[TBL] [Abstract][Full Text] [Related]
11. The effects of lifestyle factors on the incidence of nocturia.
Shiri R; Hakama M; Häkkinen J; Auvinen A; Huhtala H; Tammela TL; Koskimäki J
J Urol; 2008 Nov; 180(5):2059-62. PubMed ID: 18804241
[TBL] [Abstract][Full Text] [Related]
12. Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
Hernández C; Estivill E; Prieto M; Badía X
Curr Med Res Opin; 2008 Apr; 24(4):1033-8. PubMed ID: 18302812
[TBL] [Abstract][Full Text] [Related]
13. Impact of obesity on urinary storage symptoms: results from the FINNO study.
Vaughan CP; Auvinen A; Cartwright R; Johnson TM; Tähtinen RM; Ala-Lipasti MA; Tammela TL; Markland AD; Thorlund K; Tikkinen KA
J Urol; 2013 Apr; 189(4):1377-82. PubMed ID: 23103801
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
[TBL] [Abstract][Full Text] [Related]
15. Demystifying nocturia: identifying the cause and tailoring the treatment.
Laureanno P; Ellsworth P
Urol Nurs; 2010; 30(5):276-86; quiz 287. PubMed ID: 21067093
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal Urinary Disorders and Multiple Sclerosis: Clinical and Urodynamic Study of 309 Patients.
Mauruc E; Guinet-Lacoste A; Falcou L; Manceau P; Verollet D; Le Breton F; Amarenco G
J Urol; 2017 Feb; 197(2):432-437. PubMed ID: 27816615
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, risk factors, and symptom bother of nocturia: a population-based survey in China.
Wang Y; Hu H; Xu K; Zhang X; Wang X; Na Y; Kang X
World J Urol; 2015 May; 33(5):677-83. PubMed ID: 25257983
[TBL] [Abstract][Full Text] [Related]
19. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.
Khan S; Wolin KY; Pakpahan R; Grubb RL; Colditz GA; Ragard L; Mabie J; Breyer BN; Andriole GL; Sutcliffe S
BMC Urol; 2021 Mar; 21(1):47. PubMed ID: 33773592
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes.
Chung MS; Chuang YC; Lee JJ; Lee WC; Chancellor MB; Liu RT
Int Urol Nephrol; 2014 Jul; 46(7):1269-75. PubMed ID: 24595602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
